Acute morphological sequelae of photodynamic therapy with 5-aminolevulinic acid in the C6 spheroid model

Pitr Zelenkov(Ludwig-Maximilians-Universität München), Walter Stummer(University of Münster), Roland Goldbrunner(University of Cologne), K. Bise, Ronald Sroka(Ludwig-Maximilians-Universität München), Reinhold Baumgartner(Ludwig-Maximilians-Universität München), Michael Heide(German Primate Center), Susanne Stocker(Ludwig-Maximilians-Universität München), R. Meier(Ludwig-Maximilians-Universität München)
Journal of Neuro-Oncology
September 26, 2006
10.1007/s11060-006-9252-8
Cited by 27

Related Papers

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
|The Lancet Oncology|2006|3.4k
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
|Neurosurgery|2008|1k
Fluorescence-guided resection of glioblastoma multiforme utilizing 5-ALA-induced porphyrins: a prospective study in 52 consecutive patients
|Journal of neurosurgery|2000|880
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
|The Lancet|2019|581
Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma
|Journal of Clinical Oncology|2010|445